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Memory retrievalFlavonoids are a class of polyphenolic compounds present in fruits and vegetables. Several studies have dem-
onstrated a relationship between the consumption of flavonoid-rich diets and the prevention of human
diseases including neurodegenerative disorders. Thus, we assessed the effect of quercetin (3,3′,4′,5,7-
pentahydroxyflavone) on oxidative stress and memory retrieval using a step-through passive avoidance
task in kindled rats. Quercetin (25, 50, and 100 mg/kg) was administered intraperitoneally (i.p.) before
pentylenetetrazole (PTZ) every other day prior to the training. Retention tests were performed to assessmem-
ory in rats. Compared to control, pretreatment with 50 mg/kg of quercetin could attenuate seizure severity
from the beginning of the kindling experiment by lowering the mean seizure stages. Moreover, quercetin
50 mg/kg significantly increased the step-through latency of the passive avoidance response compared to
the control in the retention test. Malondialdehyde (MDA) levels were significantly increased in the quercetin
groups compared to the PTZ group in the hippocampus and cerebral cortex following PTZ kindling. In the
quercetin groups, higher sulfhydryl (SH) contents were not observed compared to the PTZ group. These re-
sults indicate that quercetin at a specific dose results in decreased seizure severity during kindling and perfor-
mance improvement in a passive avoidance task in kindled rats. All doses of quercetin led to increased
oxidative stress in the hippocampi and cerebral cortices of kindled rats.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Pentylenetetrazole (PTZ), a selective blocker of the chloride chan-
nel coupled to the GABAA receptor complex, is the most popular
chemoconvulsant used for evaluating antiepileptic drugs [1,2].
Kindling induced by the convulsant PTZ represents a model of prima-
ry generalized epilepsy [3]. The PTZ kindling model provides a useful
model of postseizure dysfunction, which can serve as a screen for
potential treatments for those cognitive and emotional deficits often
observed in human epilepsy [4]. The effects of epilepsy on cognition
have been reviewed in several papers [5,6]. Moreover, a mild decline
in intellectual performance in children and adults with epilepsy has
been suggested [5]. Patients with localized epilepsies generally have
deficits in the cognitive functions controlled by respective areas,
such as memory impairment in temporal lobe epilepsy (TLE) [6].
There are several pieces of evidence that indicate that PTZ kindling
impairs shuttle-box performance [7–11].
Quercetin is a flavonoid (3,3′,4′,5,7-pentahydroxyflavone) found
in a variety of fruits and vegetables including apples, citrus fruits,arch Centre, Qazvin University
Fax: +98 2813324970.
hbelinejad).
rights reserved.berries, bulbs, cereal grains, onions, legumes, and tea [12,13]. Querce-
tin has several pharmacological properties, including antioxidant,
antiinflammatory, and hepatoprotective effects [12,14–18]. A high
dosage of quercetin is needed to achieve good results since quercetin
undergoes first-pass metabolism [19]. It has the ability to penetrate
the blood–brain barrier (BBB), and in some studies, the proportion of
its passage is estimated to be as high as 65.54% [20]. Quercetin metab-
olites and glycosides seem to be less neuroprotective and penetrate
the BBB less efficiently than aglycone [21]. There are several studies
about the inhibitory role of quercetin on lipid peroxidation in different
behavioral studies [22–25]. Thus, in this study, we focused on the
possible effects of quercetin on oxidative stress and memory retrieval
in kindled rats. Malondialdehyde (MDA) and sulfhydryl (SH) groups
were measured as indicators for lipid peroxidation and oxidative
stress markers.
2. Material and methods
2.1. Animals
Male Wistar rats (200–250 g) were obtained from Razi Institute
(Karaj, Iran) and housed in groups of four per cage under standard lab-
oratory conditions. They were kept at a constant room temperature
152 M. Nassiri-Asl et al. / Epilepsy & Behavior 28 (2013) 151–155(21 ± 2 °C) under a normal 12L:12D regime with free access to food
and water. All animal experiments were carried out in accordance
with the European Communities Council Directive of 24 November
1986 (86/609/EEC) in such a way as to minimize the number of
animals and their suffering.
2.2. Drugs
Quercetin and PTZwere purchased from Sigma (St. Louis, MO, USA).
Other drugs in this investigation were xylazine (Loughrea, Co. Galway,
Ireland) and ketamine (Rotexmedica, GmbH, Germany). Quercetin
and PTZ were dissolved in saline. 2,2′-Dinitro-5,5′-dithiodibenzoic
acid (DTNB), 2-thiobarbituric acid (TBA), Tris (Trizma® base), sodium
ethylenediaminetetraacetic acid (Na EDTA), methanol, trichloroacetic
acid (TCA), potassium chloride (KCL), and hydrochloric acid (HCL)
were purchased from Merck (Darmstadt, Germany).
2.3. Kindling procedure by PTZ
Rats were divided into four groups of 10 animals each. In the con-
trol group, saline was injected 30 min before administration of PTZ
every other day (35 mg/kg, i.p., 15 injections total).
After each injection, the animals were placed individually in plastic
boxes, and their convulsive behavior was recorded for 30 min; behav-
ioral changes were graded according to the criteria described by
Racine [26] as modified by Xie et al. [27]: Stage 0: no response; Stage
1: hyperactivity and vibrissae twitching; Stage 2: head nodding,
head clonus, and myoclonic jerk; Stage 3: unilateral forelimb clonus;
Stage 4: rearing with bilateral forelimb clonus; and Stage 5: general-
ized tonic–clonic seizures (GTCSs) with loss of postural control.
In the remaining three groups, 25, 50, or 100 mg/kg of quercetinwas
given 30 min before administration of PTZ every other day (35 mg/kg,
i.p., 15 injections total).
For memory testing, a group of animals with unimpaired memory
was used; they had been injected with saline instead of PTZ. This
group was used to elucidate the effects of quercetin on memory
under baseline conditions, compared with levels that were lower or
higher than the baseline.
2.4. Passive avoidance apparatus
The passive avoidance apparatus comprised a learning box con-
sisting of a light (white) and a dark (black) compartment 20 × 20 ×
30 cm each. A guillotine door opening (6 × 6 cm) was made on the
floor in the center of the partition between the two compartments.
Stainless steel grids (5 mm in diameter) were placed at 1-cm inter-
vals (distance between the centers of the grids) on the floor of the
dark compartment to produce a foot shock.
All rats were allowed to habituate to the experimental room for at
least 30 min prior to the experiments. Then, each rat was gently
placed in the light compartment of the apparatus. After 5 s, the guillo-
tine door was opened, and the rat was allowed to enter the dark com-
partment. The latency with which each rat crossed into the dark
compartment was recorded. The rats that waited more than 100 s to
cross into the dark compartment were eliminated from the experi-
ments. Once the rat crossed with all four paws into the next compart-
ment, the guillotine door was closed and the rat was taken to its home
cage. The acquisition trial was performed 30 min after the habituation
trial. The rat was placed in the light compartment, and the guillotine
door was opened 5 s later. As soon as the rat crossed into the dark
compartment, the door was closed, and a foot shock (0.5 mA in inten-
sity, 3 s) was immediately delivered to the grid floor of the dark room
by an insulated stimulator.
One day after training, retention tests were performed to evaluate
memory performance. Each rat was placed in the light compartment
for 20 s, the doorwas opened, and the step-through latency for enteringinto the dark compartmentwasmeasured. The test session endedwhen
the rat entered the dark compartment or remained in the light compart-
ment for 300 s. No electric shockwas applied during these sessions [28].
At the end of the experiments, rats were anesthetized with intraperito-
neal injections of ketamine/xylazine (60 mg/kg and 6 mg/kg, respec-
tively). Rats were sacrificed under anesthesia, and their brains were
quickly removed, cleaned with chilled saline, and used for biochemical
analysis.
2.5. Thiobarbituric acid reactive substance (TBARS) measurement
Malondialdehyde levels were measured as an index of lipid peroxi-
dation. Malondialdehyde reacts with TBA as a thiobarbituric acid reac-
tive substance (TBARS) to produce a red-colored complex with a peak
absorbance at 535 nm [29]. Brains were homogenized with cold 1.5%
KCl to make a 10% homogenate. Trichloroacetic acid–2-thiobarbituric
acid–hydrochloric acid (2.0 ml) was added to 1.0 ml of the brain ho-
mogenate and mixed thoroughly. The solution was heated for 60 min
in a boiling water bath. After cooling, the flocculent precipitate was re-
moved by centrifugation at 1000 ×g for 10 min. The absorbance was
determined at 535 nm against a blank that contained all the reagents
except the sample. The amount of MDA equivalents formed was calcu-
lated using a molar extinction coefficient of 1.56 × 105 mol−1 cm−1
and expressed as nmol MDA equivalents/mg protein.
2.6. Total sulfhydryl groups assay
Total SH groups were measured using DTNB. This reagent reacts
with SH groups to produce a yellow-colored complex with a peak
absorbance at 412 nm [30]. Briefly, 1-ml Tris–EDTA buffer (pH =
8.6) was added to 50 μl brain homogenate in 2-ml cuvettes, and the
sample absorbance was read at 412 nm against Tris–EDTA buffer
alone (A). Next, 20 μl of DTNB (10 mM in methanol) was added to
the mixture, and after 15 min (stored at laboratory temperature),
the sample absorbance was read again (A1). The absorbance of the
DTNB reagent was read as a blank (B) [31]. Total thiol concentration
(mM)was calculated using the following equation: total thiol concen-
tration (mM) = (A2 − A1 − B) × 1.07 / 0.05 × 13.6.
2.7. Data analysis
The data were analyzed using a one-way ANOVA and a post hoc
Tukey's test for multiple comparisons. A level of P b 0.05 was consid-
ered to indicate statistical significance.
3. Results
3.1. Effects of quercetin pretreatment on kindling development
The effects of different doses of quercetin during kindling are
shown in Fig. 1. The repeated application of 35-mg/kg PTZ induced be-
havioral seizures with increasing severity which culminated in clonic
convulsions at the end of the kindling procedure. Pretreatment with
different doses of quercetin (25, 50, and 100 mg/kg) before each kin-
dling injection modified the stage of kindling development in a differ-
ent manner. Pretreatment with 50 mg/kg of quercetin attenuated the
seizure severity of the kindling procedure by lowering the mean sei-
zure stages at the beginning of the kindling procedure compared to
control (P b 0.05) (Fig. 1).
3.2. Effects of quercetin pretreatment on passive avoidance test
There was no significant difference between the different groups
in the number of trials, thus confirming the uniformity of the groups.
All animals reached the criteria during the training procedure. In the
PTZ group, both the acquisition trials and memory retrieval
Fig. 1. The effects of repeated administration of different doses of quercetin (25, 50, and 100 mg/kg) on the development of PTZ-induced kindling (35 mg/kg, i.p., 15 injections total)
compared to the control group. Data are expressed as mean seizure stage ± SEM (n = 10).
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(Figs. 2A, B).
Quercetin at a dose of 50 mg/kg 30 min before the administration
of PTZ every other day (35 mg/kg, i.p, 15 injections total) prior to
training significantly increased acquisition trials and memory retriev-
al compared to the PTZ group (P b 0.01 and P b 0.05, respectively).
This effect was not dose-dependent (Figs. 2A, B). Also, there were no
significant differences in the acquisition trials and memory retrieval
between the 50-mg/kg quercetin group and the control group.3.3. Thiobarbituric acid reactive substance (TBARS) measurement
Malondialdehyde levels were increased following PTZ kindling in
both the hippocampus and cerebral cortex in all groups (Fig. 3).
However, MDA contents in the cortex were greater than those in
the hippocampus, and there were more hippocampus MDA changes
than cortex MDA changes.
Quercetin administration caused a significant elevation in free
radical-mediated lipid peroxidation, as indicated by a significant
increase in MDA levels at doses of 25, 50, and 100 mg/kg compared
to the PTZ group in the hippocampus (P b 0.001, P b 0.01, and
P b 0.001, respectively) (Fig. 3). Similarly, quercetin resulted in a
significant increase in the MDA levels at doses of 25, 50, and
100 mg/kg compared to the PTZ group in the cerebral cortex
(P b 0.01, P b 0.05, and P b 0.01, respectively) (Fig. 3).
However, in both tissues, the effect of quercetin on the elevation
of MDA levels at the dose of 50 mg/kg was less than for the other
doses of quercetin compared to the PTZ group.Fig. 2. Effects of different doses of quercetin (25, 50, and 100 mg/kg) on the step-
through latencies in acquisition trials (A) and retention trials (B) in rats. The control
group received PTZ injections every other day (35 mg/kg, i.p., 15 injections total)
prior to the experiments. In the remaining three groups, 25, 50, or 100 mg/kg of quer-
cetin was given 30 min before administration of PTZ every other day prior to the exper-
iments. Retention tests were performed one day after training, Values are expressed as
mean ± SEM. *P b 0.05, compared to control, ≠P b 0.05, ≠≠P b 0.01 compared to the
PTZ group (n = 10, Tukey–Kramer test).3.4. Total sulfhydryl groups assay
Following PTZ kindling, quercetin did not cause significant
elevation in total SH concentrations compared to the PTZ group in
the hippocampus and cerebral cortex (Fig. 4). However, the elevation
in total SH concentrations was dose-dependent in the cerebral cortex.
Fig. 3. Effect of quercetin on lipid peroxidation following PTZ kindling in hippocampus
and cerebral cortex. Values are expressed as mean ± SEM. **P b 0.01, ***P b 0.001
compared to the PTZ group in hippocampus samples. ≠P b 0.05, ≠≠P b 0.01 compared
to the PTZ group in cortex samples (n = 10, Tukey–Kramer test).
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In the present study, we investigated the possible effects of
quercetin on oxidative stress and memory retrieval in kindled rats.
Pretreatment with 50 mg/kg of quercetin attenuated seizure severity
from the beginning of the kindling procedure by lowering the mean
seizure stages compared to the control. However, this effect was not
observed at both lower and higher doses.
It was established that in the PTZ kindlingmodel, the susceptibility
to seizures following injection of initially subconvulsant doses of PTZ
was increased and culminated in GTCS. After repeated or single dose
administration of PTZ, GABAergic function is decreased, and the stim-
ulation and modification of sensitivities of different glutamate recep-
tor subtypes in many brain regions occur [32,33]. With regard to the
anticonvulsant effects of quercetin, it is possible that quercetin modu-
lates GABAA receptors, and this has been reported for other
flavonoids such as hispidulin at the specific dose range [34]. Thus,
these protective effects of quercetin may be related to its modulatory
effect on GABA receptors in this study.
On the other hand, it was reported that quercetin has procon-
vulsant activity [35]. It was also shown that the protective and toxic
effects of quercetin depend on both timing and dose [36]. Similarly
to our results, it was reported that quercetin has a narrow therapeutic
dose range in in vitro studies. Thus, the risk for neurotoxicity is not
negligible [21]. For this reason, it is possible that quercetin at a dose
of 100 mg/kg did not show any anticonvulsant effects during kindling.Fig. 4. Effect of quercetin on total thiol concentrations following PTZ kindling in the
hippocampus and cerebral cortex. Values are expressed as mean ± SEM (n = 10,
Tukey–Kramer test).Antioxidants may have prooxidant and antioxidant activities [37].
Flavonoids are known to be antioxidants that can protect the cell
from oxidative stress. However, at high concentrations, flavonoids
and other polyphenols may be cytotoxic, causing increasedmitochon-
drial permeability, cytochrome c release, caspase activation, increased
levels of p53 and p21, suppression of Bcl-2, apoptosis induction, and
necrotic cell death. They show prooxidant cytotoxicity in mammalian
cells due to the formation of free radicals and oxidation products
possessing quinone or quinomethide structure [38].
It has been established that quercetin also has prooxidant effects,
and the observed concentration-dependent cytotoxic effect of querce-
tin may be related to the intracellular metabolic activation of querce-
tin to o-quinone [39]. Low concentrations of quercetin could stimulate
cell proliferation and increase the total antioxidant capacity (TAC) of
the cells, while higher concentrations decreased cell survival and via-
bility, thiol content, TAC, and activities of superoxide dismutase, cata-
lase, and glutathione S-transferase. Furthermore, quercetin decreased
reactive oxygen species (ROS) production in cells but produced perox-
ides in the medium. Thus, it has been suggested that quercetin has
complex oxidative and antioxidative effects [40]. Accordingly, it is
possible that both the prooxidant and antioxidant effects of quercetin
may be involved in the different effects of quercetin on the seizure
threshold in kindled rats.
In this study, pretreatmentwith quercetin before administration of
PTZ every other day and prior to training was followed by enhanced
memory retrieval in rats. Quercetin 50 mg/kg significantly enhanced
memory retrieval in the retention tests of a passive avoidance task
compared to the control.
The direct role of flavonoids in memory acquisition, consolidation,
and storage has been described previously in a study involving in-
duced activation of neuronal signaling and gene expression in the
brain. The results indicated that this may lead to changes in synaptic
plasticity and neurogenesis in the brain, ultimately influencing mem-
ory, learning, and cognition [41].
Reactive oxygen species have been implicated in PTZ-induced sei-
zures and kindling in brains lacking cerebella [33]. In addition, PTZ ad-
ministration at a convulsant dose caused significant increases in
whole brain fatty acid content in the rat hippocampus [42]. The activ-
ities of necessary rat brainmetabolic enzymes changed in PTZ-kindled
rats, and these changes occurred mainly in the frontal cortex [43].
In the current study, quercetin significantly increased MDA levels
in the hippocampus and cerebral cortex following PTZ kindling in the
quercetin groups compared to the PTZ group. However, this enhanc-
ing effect of quercetin at a dose of 50 mg/kg was less than for other
doses. Furthermore, as our results show, it seems that the content of
MDA changes between the quercetin groups in the hippocampus
was more than that found in the cerebral cortex. In kindled animals
with quercetin treatment, higher SH contents were not observed
compared to the PTZ group.
Similarly, it was reported recently that MDA and protein carbonyl-
ation (PC) levels were higher in patients with epilepsy compared to a
control group, and there was no difference in oxidation levels be-
tween untreated and treated patients [44]. In addition, patients with
epilepsy treated with phenytoin and valproate had increased MDA
levels [45,46]. It has also been shown that a quercetin-enriched diet
results in increased levels of quercetin and its metabolites in the
mouse brain. However, it did not change mRNA levels of antioxidants
and genes relevant to Alzheimer's disease [47].
5. Conclusion
In our study, we observed that quercetin has anticonvulsant
effects and enhanced memory retrieval in the passive avoidance
task, but it also increased oxidative stress in kindled animals. Thus,
quercetin could not be effective against oxidative stress in the hippo-
campus and cerebral cortex in kindled rats besides its anticonvulsant
155M. Nassiri-Asl et al. / Epilepsy & Behavior 28 (2013) 151–155effects and protection against memory impairment at a dose of
50 mg/kg. Further study is necessary to evaluate the molecular mech-
anisms of quercetin during PTZ kindling.
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